Sfoglia per AUTORE
DI MAIO M
Collezione AO Ordine Mauriziano

  

Items : 227

2025
AO Ordine Mauriziano

Pignata S; Oza A; Hall G; Pardo B; Madry R; Cibula D; Klat J; Montes A; Glasspool R; Colombo N; Pete I; Herrero Ibáñez A; Romeo M; Ilieva R; Timcheva C; Di Maio M; Bashir Z; Taylor R; Barnicle A; Clamp A;

Viral Hepatitis in Western Patients with Advanced Intrahepatic Cholangiocarcinoma: Retrospective Assessment of Prevalence, Prognostic and Predictive Significance. in Cancer investigation / Cancer Invest. 2025 Jan;43(1):59-69. doi: 10.1080/07357907.2024.2432013. Epub 2024 Nov 27.
2025
ASL Biella
AO Ordine Mauriziano

Brunetti O; Rimini M; Tavolari S; Palloni A; Deserti M; Faloppi L; Scartozzi M; Santini D; Aprile G; Lutrino SE; Sperti E; Salani F; Satolli MA; Silvestris N; Leone F; Casadei-Gardini A; Filippi R; Brandi G; Spadi R; Ilaria D; Di Maio M;

Advancing treatment choices: CDK4/6 inhibitor switching in HR+/HER2- metastatic breast cancer. in Breast (Edinburgh, Scotland) / Breast. 2025 Feb;79:103875. doi: 10.1016/j.breast.2025.103875. Epub 2025 Jan 10.
2025
AO Ordine Mauriziano

Zagami P; Esposito A; Taurelli Salimbeni B; Berton Giachetti PPM; Scafetta R; Lambertini M; Di Maio M; Curigliano G; Criscitiello C; Cinieri S;

2025
AO Ordine Mauriziano

Piscaglia F; Masi G; Martinelli E; Cabibbo G; Di Maio M; Gasbarrini A; Iavarone M; Antonuzzo L; Mazzaferro V; Ballestrero A; Garufi C; Bergamo F; Celsa C; Marino D; Tovoli F; Ponziani FR; Pressiani T; Astolfi C; Gazzoli GC; Ciardiello F; Daniele B; Rimassa L;

Withdrawal notice to . in The Lancet regional health. Europe / Lancet Reg Health Eur. 2024 Sep 2;44:101012. doi: 10.1016/j.lanepe.2024.101012. eCollection 2024 Sep
2024
AO Ordine Mauriziano

Iacovino ML; Celant S; Tomassini L; Arenare L; Caglio A; Canciello A; Salerno F; Olimpieri PP; Di Segni S; Sferrazza A; Piccirillo MC; Beretta GD; Pinto C; Blasi L; Cinieri S; Cavanna L; Di Maio M; Russo P; Perrone F;

Safety profile of darolutamide versus placebo: a systematic review and meta-analysis. in Prostate cancer and prostatic diseases / Prostate Cancer Prostatic Dis. 2024 Sep;27(3):385-392. doi: 10.1038/s41391-023-00775-y. Epub 2023 De
2024
ASL Asti
AO Ordine Mauriziano

Di Maio M; Buttigliero C; Cathomas R; Tombal B; Smith MR; Fizazi K; Treglia G; Gillessen S; Turco F; Tucci M; Vogl UM; Turco F; Gillessen S; Treglia G; Fizazi K; Smith MR; Tombal B; Cathomas R; Buttigliero C; Di Maio M; Tucci M; Vogl UM;

Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Oct;22(5):102138. doi: 10.1016/j.clgc.2024.102138. Epub 2024 Jun 12.
2024
ASL Asti
AO Ordine Mauriziano

Palesandro E; Di Maio M; Poletto S; Crespi V; Saporita I; Calabrese M; Farinea G; Di Stefano RF; Gallina A; Fossati N; Zilli T; Vogl UM; Gillessen S; Delcuratolo MD; Buttigliero C; Turco F; Scagliotti GV; Tucci M;

2024
AO Ordine Mauriziano

Gandaglia G; Briganti A; Raggi D; Marandino L; Necchi A; Di Maio M; Montorsi F; Gandaglia G; Briganti A; Raggi D; Marandino L; Necchi A; Di Maio M; Montorsi F;

Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2024 May;197:104328. doi: 10.1016/j.critrevonc.2024.104328. Epub 2024 Mar 13
2024
ASL Torino 4
AO Ordine Mauriziano

Novello S; Vellani G; Sperone P; Vignani F; Dionisio R; Paratore C; Ferrari G; Valsecchi AA; Di Maio M;

Treatment of bone metastases from solid tumors with bone-modifying agents: a web survey of Italian oncologists investigating patterns of practice drug prescription and prevention of side effects. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2024 Mar 1;32(3):202. doi: 10.1007/s00520-024-08392-8.
2024
ASL Asti
AOU Alessandria
AO Ordine Mauriziano

Cinieri S; Rossetti G; Airoldi M; Rossi M; Lanzetta G; Cavanna L; Ibrahim T; Bossi P; Santini D; Tucci M; De Giorgi U; Valsecchi AA; Comandone A; Di Maio M; Fusco V;

Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System. in JCO oncology practice / JCO Oncol Pract. 2024 Mar;20(3):438-447. doi: 10.1200/OP.23.00434. Epub 2024 Jan 11.
2024
AO Ordine Mauriziano

Sparano F; Giesinger JM; Gaidano G; Anota A; Cavo M; Brini A; Voso MT; Venditti A; Perrone F; Di Maio M; Luppi M; Baron F; Platzbecker U; Fazi P; Vignetti M; Efficace F;

Management of cancer treatment-induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey. in Tumori / Tumori. 2024 Jun;110(3):174-185. doi: 10.1177/03008916241236279. Epub 2024 Mar 10.
2024
ASL Asti
AOU Alessandria
AO Ordine Mauriziano

Vignani F; Cinieri S; Dionisio R; De Giorgi U; Tucci M; Di Maio M; Santini D; Fusco V; Valsecchi AA;

Intravenous antiplatelet therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention : A report from the INVEST-STEMI group. in Journal of thrombosis and thrombolysis / J Thromb Thrombolysis. 2024 Jun;57(5):757-766. doi: 10.1007/s11239-024-02970-7. Epub 2024 Apr 13.
2024
AO Cuneo
AO Ordine Mauriziano

Valenti R; Personeni D; Parodi G; Musumeci G; Muraca I; Maiellaro F; Granata G; Esposito L; Cesaro A; Di Maio M; Centore M; Catalano A; Baldi C; Attisano T; Scudiero F; Bellino M; Silverio A; Vecchione C; Calabrò P; Galasso G;

Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study. in The Lancet regional health. Europe / Lancet Reg Health Eur. 2024 Apr 22;41:100912. doi: 10.1016/j.lanepe.2024.100912. eCollection 2024 Ju
2024
AO Ordine Mauriziano

Iacovino ML; Celant S; Tomassini L; Arenare L; Caglio A; Canciello A; Salerno F; Olimpieri PP; Di Segni S; Sferrazza A; Piccirillo MC; Beretta GD; Pinto C; Blasi L; Cinieri S; Cavanna L; Di Maio M; Russo P; Perrone F;

2024
AO Ordine Mauriziano

Iacovino ML; Celant S; Tomassini L; Arenare L; Caglio A; Canciello A; Salerno F; Olimpieri PP; Di Segni S; Sferrazza A; Piccirillo MC; Domenico Beretta G; Pinto C; Blasi L; Cinieri S; Cavanna L; Di Maio M; Russo P; Perrone F;

2024
AO Ordine Mauriziano

Iacovino ML; Celant S; Tomassini L; Arenare L; Caglio A; Canciello A; Salerno F; Olimpieri PP; Di Segni S; Sferrazza A; Piccirillo MC; Beretta GD; Pinto C; Blasi L; Cinieri S; Cavanna L; Di Maio M; Russo P; Perrone F;

Meta-Analysis on the Combination of Chemotherapy With Programmed Death-Ligand 1 and Programmed Cell Death Protein 1 Blockade as First-Line Treatment for Unresectable Pleural Mesothelioma. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2024 Jan;19(1):166-172. doi: 10.1016/j.jtho.2023.08.004. Epub 2023 Aug 9.
2024
AO Ordine Mauriziano

Besse B; Barlesi F; Novello S; Aldea M; Le Péchoux C; Facchinetti F; Genova C; Remon J; Bironzo P; Di Maio M; Tagliamento M; Planchard D;

Italian oncologists and vaccinations against infectious diseases: Results of a survey of the Italian Association of Medical Oncology. in Tumori / Tumori. 2024 Feb;110(1):60-68. doi: 10.1177/03008916231191547. Epub 2023 Aug 10.
2024
AO Ordine Mauriziano

Di Maio M; Pedrazzoli P; Silvestris N; Brunello A; Lasagna A; Cinieri S;

2024
AO Ordine Mauriziano

Di Maio M; Loupakis F; Cirnigliaro G; Cerioli M; Boscacci M; Achilli F; Cafaro R; Gesi C; Dell'Osso B;

A neuroligin-2-YAP axis regulates progression of pancreatic intraepithelial neoplasia. in EMBO reports / EMBO Rep. 2024 Apr;25(4):1886-1908. doi: 10.1038/s44319-024-00104-x. Epub 2024 Feb 27.
2024
AO Ordine Mauriziano

Middonti E; Astanina E; Vallariello E; Hoza RM; Metovic J; Spadi R; Cristiano C; Papotti M; Allavena P; Novelli F; Parab S; Cappello P; Scarpa A; Lawlor R; Di Maio M; Arese M; Bussolino F;

Which patients should receive electronic patient-reported outcome measures in clinical practice? in Cancer / Cancer. 2023 Sep 15;129(18):2915-2916. doi: 10.1002/cncr.34954. Epub 2023 Jul 11.
2023
AO Ordine Mauriziano

Di Maio M;

2023
AO Ordine Mauriziano

Napolitano S; Ciardiello D; De Falco V; Martini G; Martinelli E; Della Corte CM; Esposito L; Famiglietti V; Di Liello A; Avallone A; Cardone C; De Stefano A; Montesarchio V; Zampino MG; Fazio N; Di Maio M; Del Tufo S; De Vita F; Altucci L; Marrone F; Ciardiello F; Troiani T;

Poly (ADP-Ribose) Polymerase Inhibitors in Patients With Urothelial Cancer. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2023 Oct;21(5):509-516. doi: 10.1016/j.clgc.2023.07.009. Epub 2023 Jul 20.
2023
AO Ordine Mauriziano

Gamba T; Paparo J; Panepinto O; Dionisio R; Di Maio M; Vignani F;

Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society. in Tumori / Tumori. 2023 Oct;109(5):490-495. doi: 10.1177/03008916221146820. Epub 2023 Jan 6.
2023
ASL Torino 5
AO Ordine Mauriziano

Artioli G; Valabrega G; Purro A; Mammoliti S; Testa S; Scotto G; Turinetto M; Bellero M; Milani A; Tuninetti V; Pignata S; Biglia N; Scandurra G; Mangili G; Di Maio M; De Giorgi U; Savarese A; Castaldo D; Lorusso D;

Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis. in iScience / iScience. 2023 Sep 22;26(11):107970. doi: 10.1016/j.isci.2023.107970. eCollection 2023 Nov 17.
2023
AO Ordine Mauriziano

Anpalakhan S; Signori A; Cortellini A; Verzoni E; Giusti R; Aprile G; Ermacora P; Catino A; Pipitone S; Di Napoli M; Scotti V; Mazzoni F; Guglielmini PF; Veccia A; Maruzzo M; Schinzari G; Casadei C; Grossi F; Rizzo M; Montesarchio V; Verderame F; Mencoboni M; Zustovich F; Fratino L; Accettura C; Cinieri S; Tondini CA; Camerini A; Banzi MC; et alii...

Position paper of the Italian association of medical oncology on health disparities among transgender and gender-diverse people: the Assisi recommendations. in EClinicalMedicine / EClinicalMedicine. 2023 Oct 17;65:102277. doi: 10.1016/j.eclinm.2023.102277. eCollection 2023 Nov.
2023
AO Ordine Mauriziano

Leone AG; Casolino R; Trapani D; Miceli R; Massagrande M; Morano F; La Verde N; Dalu D; Berardi R; Marsoni S; Lambertini M; Iula B; Carieri E; Converti M; Di Maio M; Beretta GD; Perrone F; Pietrantonio F; Cinieri S;

Preexisting evidence and outcome of phase III trials in gastrointestinal oncology: a systematic review. in Journal of the National Cancer Institute / J Natl Cancer Inst. 2023 May 8;115(5):505-513. doi: 10.1093/jnci/djad030.
2023
AO Ordine Mauriziano

Bregni G; Trevisi E; Saúde Conde R; Vanhooren M; Akin Telli T; Assaf I; Hendlisz A; Di Maio M; Sclafani F;

The Value of Patient-Reported Outcomes in Single-Arm Cancer Trials. in Cancer investigation / Cancer Invest. 2023 May;41(5):491-494. doi: 10.1080/07357907.2023.2206497. Epub 2023 May 2.
2023
AO Ordine Mauriziano

Di Maio M;

2023
AO Ordine Mauriziano

Pignata S; Oza A; Hall G; Pardo B; Madry R; Cibula D; Klat J; Montes A; Glasspool R; Colombo N; Pete I; Herrero Ibáñez A; Marín MR; Ilieva R; Timcheva C; Di Maio M; Blakeley C; Taylor R; Barnicle A; Clamp A;

Real-world retrospective study of KRAS mutations in advanced non-small cell lung cancer in the era of immunotherapy. in Cancer / Cancer. 2023 Jun 1;129(11):1662-1671. doi: 10.1002/cncr.34731. Epub 2023 Mar 11.
2023
AO Ordine Mauriziano

Bironzo P; Cani M; Jacobs F; Napoli VM; Listì A; Passiglia F; Righi L; Di Maio M; Novello S; Scagliotti GV;

2023
AO Ordine Mauriziano

Pedrazzoli P; Lasagna A; Cassaniti I; Piralla A; Squeri A; Bruno R; Sacchi P; Baldanti F; Di Maio M; Beretta GD; Cinieri S; Silvestris N;

2023
AO Ordine Mauriziano

Leone AG; Miceli R; Trapani D; Massagrande M; Morano F; Marsoni S; La Verde N; Berardi R; Casolino R; Lambertini M; Dalu D; Di Maio M; Beretta GD; Perrone F; Cinieri S; Pietrantonio F;

2023
ASL Torino 4
AO Ordine Mauriziano

Formisano L; Santaniello A; Viscardi G; Di Costanzo F; Paratore C; Napolitano F; Salomone F; Di Maio M; Servetto A; Bianco R;

2023
AO Ordine Mauriziano

Tuninetti V; Pace L; Ghisoni E; Quarà V; Arezzo F; Palicelli A; Mandato VD; Geuna E; Cormio G; Biglia N; Borsotti L; Gallo S; Ferrero A; Jacomuzzi E; Fuso L; Pezua Sanjinez JOS; Puppo A; Caglio A; Rognone C; Turinetto M; Scotto G; Di Maio M; Valabrega G;

2023
AO Ordine Mauriziano

Napolitano S; De Falco V; Martini G; Ciardiello D; Martinelli E; Della Corte CM; Esposito L; Famiglietti V; Di Liello A; Avallone A; Cardone C; De Stefano A; Montesarchio V; Zampino MG; Bordonaro R; Scartozzi M; Santini D; Di Maio M; De Vita F; Altucci L; Marrone F; Ciardiello F; Troiani T;

Trastuzumab deruxtecan for breast cancer: do patients experience a comprehensive benefit? in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2023 Jul;34(7):567-568. doi: 10.1016/j.annonc.2023.05.011.
2023
AO Ordine Mauriziano

Mosele F; Di Maio M;

2023
AO Ordine Mauriziano

Bersanelli M; Verzoni E; Cortellini A; Giusti R; Calvetti L; Ermacora P; Di Napoli M; Catino A; Guadalupi V; Guaitoli G; Scotti V; Mazzoni F; Veccia A; Guglielmini PF; Perrone F; Maruzzo M; Rossi E; Casadei C; Montesarchio V; Grossi F; Rizzo M; Travagliato Liboria MG; Mencoboni M; Zustovich F; Fratino L; Accettura C; Cinieri S; Camerini A; Sorarù M; et alii...

2023
AO Ordine Mauriziano

Persano I; Cani M; Del Rio B; Ferrari G; Garbo E; Parlagreco E; Pisano C; Cetoretta V; Delcuratolo MD; Turco F; Audisio A; Cecchi C; Leone G; Napoli VM; Bertaglia V; Bianco V; Capelletto E; D'Amiano C; Di Maio M; Gianetta M; Novello S; Passiglia F; Scagliotti GV; Bironzo P;

Therapeutic sequencing in advanced renal cell carcinoma: How to choose considering clinical and biological factors. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2023 Jan;181:103881. doi: 10.1016/j.critrevonc.2022.103881. Epub 2022 Nov 24
2023
ASL Asti
AO Ordine Mauriziano

Buttigliero C; Di Maio M; Scagliotti GV; Brusa F; Audisio A; Samuelly A; Audisio M; Di Stefano RF; Ungaro A; Turco F; Tucci M; Delcuratolo MD;

2023
AO Ordine Mauriziano

Procopio G; Lolli C; Di Napoli M; Pignata S; Ignazzi G; Gamba T; Veccia A; Scandurra G; Hamzaj A; Ermacora P; Masini C; Aieta M; Atzori F; Stellato M; Carella C; Bimbatti D; Giannatempo P; De Giorgi U; Vignani F; Tambaro R; Pierantoni F; Zonno A; Santini D; Di Maio M;

2023
AO Ordine Mauriziano

Tuninetti V; Ghisoni E; Pignata S; Picardo E; Raspagliesi F; Andreetta C; Maldi E; Artioli G; Mammoliti S; Zanchi L; Sikokis A; Biglia N; Parisi A; Mandato VD; Carella C; Cormio G; Marinaccio M; Puppo A; Paolini B; Borsotti L; Scotto G; Turinetto M; Sangiolo D; Di Maio M; Valabrega G;

Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint Inhibitors. in JAMA network open / JAMA Netw Open. 2023 Feb 1;6(2):e230490. doi: 10.1001/jamanetworkopen.2023.0490.
2023
AO Ordine Mauriziano

Goldstein DA; Ginsberg GM; Hofnung-Gabbay D; De Abreu Lourenco R; Loong HH; Goh BC; Chan KKW; Di Maio M; Perrone F; Hall PS; Zer A; Rosenbaum E;

Immune checkpoint blockers in patients with unresectable or metastatic thymic epithelial tumours: A meta-analysis. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2023 Feb;180:117-124. doi: 10.1016/j.ejca.2022.12.005. Epub 2022 Dec 12.
2023
AO Ordine Mauriziano

Remon J; Villacampa G; Facchinetti F; Di Maio M; Marcuse F; Tiseo M; Hochstenbag M; Hendriks LEL; Besse B; Remon J; Villacampa G; Facchinetti F; Di Maio M; Marcuse F; Tiseo M; Hochstenbag M; Hendriks LEL; Besse B;

Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study. in Breast (Edinburgh, Scotland) / Breast. 2023 Dec;72:103583. doi: 10.1016/j.breast.2023.103583. Epub 2023 Sep 25.
2023
AO Ordine Mauriziano

Di Maio M; Bighin C; Schettini F; Ruelle T; Marandino L; Fabi A; De Angelis C; Giuliano M; De Placido P; De Laurentiis M; Riccardi F; Picotto C; Puglisi F; Del Mastro L; Arpino G;

Systematic review of adoption, reporting and impact of health-related quality of life in phase III non-inferiority trials of systemic oncology treatments. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2023 Dec;195:113374. doi: 10.1016/j.ejca.2023.113374. Epub 2023 Oct 22.
2023
AO Ordine Mauriziano

Notarnicola S; Zumstein L; Paparo J; Marandino L; Perrone F; Di Maio M;

Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patients. in ESMO open / ESMO Open. 2023 Dec;8(6):102192. doi: 10.1016/j.esmoop.2023.102192. Epub 2023 Dec 5.
2023
AO Ordine Mauriziano

Arenare L; Porta C; Barberio D; Terzolo S; Zagonel V; Pisconti S; Del Mastro L; Pinto C; Bilancia D; Cinieri S; Rizzo M; Migliaccio G; Montesarchio V; Del Campo L; De Lorenzo F; Iannelli E; Traclò F; Gitto L; Vaccaro MC; Frontini L; Giannarelli D; Bryce J; Piccirillo MC; Jommi C; Efficace F; Riva S; Di Maio M; Gallo C; Perrone F; et alii...

Clinical value of offering multiple chemotherapy lines to a luminal-like metastatic breast cancer: A case report with eribulin. in Tumori / Tumori. 2023 Dec;109(6):NP1-NP5. doi: 10.1177/03008916221141929. Epub 2022 Dec 8.
2023
AO Ordine Mauriziano

Di Maio M; Manfredi M; Pirro V; Paparo J; Valsecchi AA; Dionisio R;

Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2023 Aug;189:112920. doi: 10.1016/j.ejca.2023.05.008. Epub 2023 May 15.
2023
ASL Cuneo 2
AO Cuneo
ASL Torino 4
AO Ordine Mauriziano

Perrone F; Fabi A; Trastu F; Tuninetti V; Turco F; Reale ML; Paratore C; Mariniello A; Marandino L; Ghisoni E; Lombardi P; Gargiulo P; Gamba T; Di Liello R; Bungaro M; Caglio A; Di Maio M; Audisio M; Rossi A; Aimar G;

2023
AO Ordine Mauriziano

Valsecchi AA; Dionisio R; Panepinto O; Paparo J; Palicelli A; Vignani F; Di Maio M;

2023
ASL Asti
AO Ordine Mauriziano

Di Maio M; Buttigliero C; Scagliotti GV; Ungaro A; Parlagreco E; Audisio M; Audisio A; Samuelly A; Pisano C; Urban S; Parente A; Di Stefano RF; Tucci M; Angusti T; Turco F;

Corrigendum: Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors. in Frontiers in oncology / Front Oncol. 2024 Jan 22;13:1357793. doi: 10.3389/fonc.2023.1357793. eCollection 2023.
2023
AO Ordine Mauriziano

Arezzo F; Giannone G; Castaldo D; Scotto G; Tuninetti V; Turinetto M; Bartoletti M; Mammoliti S; Artioli G; Mangili G; Salutari V; Lorusso D; Cormio G; Loizzi V; Zamagni C; Savarese A; Di Maio M; Ronzino G; Pisano C; Pignata S; Valabrega G; Arezzo F; Giannone G; Castaldo D; Scotto G; Tuninetti V; Turinetto M; Bartoletti M; Mammoliti S; et alii...

Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors. in Frontiers in oncology / Front Oncol. 2023 Sep 14;13:1247291. doi: 10.3389/fonc.2023.1247291. eCollection 2023.
2023
AO Ordine Mauriziano

Arezzo F; Giannone G; Castaldo D; Scotto G; Tuninetti V; Turinetto M; Bartoletti M; Mammoliti S; Artioli G; Mangili G; Salutari V; Lorusso D; Cormio G; Loizzi V; Zamagni C; Savarese A; Di Maio M; Ronzino G; Pisano C; Pignata S; Valabrega G;

Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study. in BMJ oncology / BMJ Oncol. 2023 Mar 2;2(1):e000021. doi: 10.1136/bmjonc-2022-000021. eCollection 2023.
2023
AO Cuneo
AO Ordine Mauriziano

Turco F; Tuninetti V; Rossi A; Paratore C; Gargiulo P; Gamba T; Di Liello R; Caglio A; Bungaro M; Audisio M; Aimar G; Reale ML; Lombardi P; Mariniello A; Ghisoni E; Trastu F; Marandino L; Perrone F; Di Maio M;

The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Sep;33(9):878-892. doi: 10.1016/j.annonc.2022.04.007. Epub 2022 Apr 21.
2022
AO Ordine Mauriziano

Di Maio M; Basch E; Denis F; Fallowfield LJ; Ganz PA; Howell D; Kowalski C; Perrone F; Stover AM; Sundaresan P; Warrington L; Zhang L; Apostolidis K; Freeman-Daily J; Ripamonti CI; Santini D;

2022
AO Ordine Mauriziano

Mariniello A; Tabbò F; Indellicati D; Tesauro M; Rezmives NA; Reale ML; Listì A; Capelletto E; Carnio S; Bertaglia V; Mecca C; Consito L; De Filippis M; Bungaro M; Paratore C; Di Maio M; Passiglia F; Righi L; Sangiolo D; Novello S; Geuna M; Bironzo P;

2022
AO Ordine Mauriziano

Maiorano BA; De Giorgi U; Roviello G; Messina C; Altavilla A; Cattrini C; Mennitto A; Maiello E; Di Maio M;

Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2022 Oct;174:200-211. doi: 10.1016/j.ejca.2022.07.026. Epub 2022 Aug 28.
2022
AO Ordine Mauriziano

Tabbò F; Muscarella LA; Gobbini E; Trombetta D; Castellana S; Rigutto A; Galetta D; Maiello E; Martelli O; Tiseo M; Scotti V; Ghilardi L; Gregorc V; Sergi C; Pilotto S; Del Conte A; Cappuzzo F; Cortinovis D; Osman G; Bareggi C; Di Maio M; Rossi A; Rossi G; Bria E; Volante M; Scagliotti GV; Graziano P; Novello S; Righi L; et alii...

2022
AO Ordine Mauriziano

Ciardiello D; Chiarazzo C; Famiglietti V; Damato A; Pinto C; Zampino MG; Castellano G; Gervaso L; Zaniboni A; Oneda E; Rapisardi S; Bordonaro R; Zichi C; De Vita F; Di Maio M; Parisi A; Giampieri R; Berardi R; Lavacchi D; Antonuzzo L; Tamburini E; Maiorano BA; Parrella P; Latiano TP; Normanno N; De Stefano A; Avallone A; Martini G; Napolitano S; et alii...

Efficacy and safety of PARP inhibitors in elderly patients with advanced ovarian cancer: a systematic review and meta-analysis. in International journal of gynecological cancer : official journal of the International Gynecological Cancer Society / Int J Gynecol Cancer. 2022 Nov 7;32(11):1410-1418. doi: 10.1136/ijgc-2022-003614.
2022
AO Ordine Mauriziano

Maiorano BA; Maiorano MFP; Lorusso D; Di Maio M; Maiello E;

Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial. in International journal of cancer / Int J Cancer. 2022 Nov 15;151(10):1760-1769. doi: 10.1002/ijc.34156. Epub 2022 Jun 23.
2022
AO Ordine Mauriziano

Raimondi A; Randon G; Prisciandaro M; Pagani F; Lonardi S; Antoniotti C; Bozzarelli S; Sartore-Bianchi A; Tampellini M; Fanchini L; Murialdo R; Clavarezza M; Zaniboni A; Berenato R; Ratti M; Petrelli F; Antonuzzo L; Giordano M; Rossi A; Di Bartolomeo M; Di Maio M; Pietrantonio F; Morano F;

MEK inhibitor as single agent in low grade serous ovarian and peritoneal cancer: a systematic review and meta-analysis. in Cancer treatment reviews / Cancer Treat Rev. 2022 Nov;110:102458. doi: 10.1016/j.ctrv.2022.102458. Epub 2022 Aug 24.
2022
AO Ordine Mauriziano

Musacchio L; Valsecchi AA; Salutari V; Valabrega G; Camarda F; Tuninetti V; Giannone G; Bartoletti M; Marchetti C; Pignata S; Fagotti A; Scambia G; Di Maio M; Lorusso D;

Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O(6)-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2022 May 10;40(14):1562-1573. doi: 10.1200/JCO.21.02583. Epub 2022 Mar 8.
2022
AO Ordine Mauriziano

Morano F; Raimondi A; Pagani F; Lonardi S; Salvatore L; Cremolini C; Murgioni S; Randon G; Palermo F; Antonuzzo L; Pella N; Racca P; Prisciandaro M; Niger M; Corti F; Bergamo F; Zaniboni A; Ratti M; Palazzo M; Cagnazzo C; Calegari MA; Marmorino F; Capone I; Conca E; Busico A; Brich S; Tamborini E; Perrone F; Di Maio M; et alii...

Impact of Blinding on Patient-Reported Outcome Differences Between Treatment Arms in Cancer Randomized Controlled Trials. in Journal of the National Cancer Institute / J Natl Cancer Inst. 2022 Mar 8;114(3):471-474. doi: 10.1093/jnci/djab177.
2022
AO Ordine Mauriziano

Efficace F; Cella D; Aaronson NK; Calvert M; Cottone F; Di Maio M; Perrone F; Sparano F; Gamper EM; Vignetti M; Giesinger JM;

New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine? in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jun;174:103682. doi: 10.1016/j.critrevonc.2022.103682. Epub 2022 Apr 11
2022
ASL Asti
AO Ordine Mauriziano

Scagliotti GV; Di Maio M; Ortega C; Di Prima L; Audisio A; Turco F; Ungaro A; Parlagreco E; Di Stefano RF; Tucci M; Audisio M; Buttigliero C;

2022
AO Ordine Mauriziano

Russo A; Incorvaia L; Capoluongo E; Tagliaferri P; Gori S; Cortesi L; Genuardi M; Turchetti D; De Giorgi U; Di Maio M; Barberis M; Dessena M; Del Re M; Lapini A; Luchini C; Jereczek-Fossa BA; Sapino A; Cinieri S;

Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index. in Journal of gastrointestinal cancer / J Gastrointest Cancer. 2022 Jun;53(2):289-298. doi: 10.1007/s12029-021-00596-z. Epub 2021 Feb 5.
2022
ASL Biella
AO Ordine Mauriziano

Cascinu S; Orsi G; Aprile G; Jeong JH; de Braud F; Vasile E; De Lorenzo S; Di Maio M; Pella N; Nichetti F; Fenocchio E; Lai E; Cho H; Vivaldi C; Palloni A; Aglietta M; Faloppi L; Santini D; Casagrande M; Silvestris N; Filippi R; Caputo F; Yoo C; Scartozzi M; Niger M; Fornaro L; Brandi G; Leone F; Rovesti G; et alii...

Impact of Novel Hormonal Therapy on Cognitive Function: Essential to Measure, Difficult to Present. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2022 Jul 1;40(19):2174-2175. doi: 10.1200/JCO.22.00092. Epub 2022 Apr 21.
2022
AO Ordine Mauriziano

Marandino L; Raggi D; Necchi A; Di Maio M;

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status. in Journal of hematology & oncology / J Hematol Oncol. 2022 Jan 21;15(1):9. doi: 10.1186/s13045-022-01226-2.
2022
AO Ordine Mauriziano

Cortellini A; Giusti R; Filetti M; Citarella F; Adamo V; Santini D; Buti S; Nigro O; Cantini L; Di Maio M; Aerts JGJV; Bria E; Bertolini F; Ferrara MG; Ghidini M; Grossi F; Guida A; Berardi R; Morabito A; Genova C; Mazzoni F; Antonuzzo L; Gelibter A; Marchetti P; Chiari R; Macerelli M; Rastelli F; Della Gravara L; Gori S; et alii...

Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21). in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2022 Jan;22(1):115-121. doi: 10.1080/14737140.2022.2002688. Epub 2021 No
2022
AO Ordine Mauriziano

Procopio G; De Braud FG; Verzoni E; Pignata S; Ottini A; Guadalupi V; Claps M; Sepe P; Stellato M; Roviello G; Buttigliero C; Di Lorenzo G; Mucciarini C; Messina C; Sorarù M; Casadei C; Santini D; Buti S; De Giorgi U; Bimbatti D; Di Maio M; Mennitto A; Zattarin E;

2022
ASL Asti
AO Ordine Mauriziano

Scagliotti GV; Di Maio M; Delcuratolo MD; Turco F; Pisano C; Di Prima L; Audisio A; Tucci M; Ungaro A; Buttigliero C;

Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors. in JAMA network open / JAMA Netw Open. 2022 Feb 1;5(2):e220290. doi: 10.1001/jamanetworkopen.2022.0290.
2022
AO Ordine Mauriziano

Pusceddu S; Prinzi N; Tafuto S; Ibrahim T; Filice A; Brizzi MP; Panzuto F; Baldari S; Grana CM; Campana D; Davì MV; Giuffrida D; Zatelli MC; Partelli S; Razzore P; Marconcini R; Massironi S; Gelsomino F; Faggiano A; Giannetta E; Bajetta E; Grimaldi F; Cives M; Cirillo F; Perfetti V; Corti F; Ricci C; Giacomelli L; Porcu L; et alii...

Can we identify a preferred first-line strategy for sarcomatoid renal cell carcinoma? A network meta-analysis. in Immunotherapy / Immunotherapy. 2022 Feb;14(2):145-153. doi: 10.2217/imt-2021-0157. Epub 2021 Nov 22.
2022
AO Ordine Mauriziano

Brunelli M; Cattrini C; Mazzaschi G; Bersanelli M; Buti S; Di Maio M;

Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations. in Journal for immunotherapy of cancer / J Immunother Cancer. 2022 Feb;10(2):e004374. doi: 10.1136/jitc-2021-004374.
2022
AO Ordine Mauriziano

Cortellini A; Ricciuti B; Vaz VR; Soldato D; Alessi JV; Dall'Olio FG; Banna GL; Muthuramalingam S; Chan S; Majem M; Piedra A; Lamberti G; Andrini E; Addeo A; Friedlaender A; Facchinetti F; Gorría T; Mezquita L; Hoton D; Valerie L; Nana FA; Artingstall J; Comins C; Di Maio M; Caglio A; Cave J; McKenzie H; Newsom-Davis T; Evans JS; et alii...

Comments on "Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)". in International journal of cancer / Int J Cancer. 2022 Dec 15;151(12):2291-2292. doi: 10.1002/ijc.34246. Epub 2022 Sep 5.
2022
AO Ordine Mauriziano

Cattrini C; Messina C; Mennitto A; Di Maio M; Gennari A; Olmos D;

Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective study. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Dec;74(6):703-713. doi: 10.23736/S2724-6051.22.04701-2. Epub 2022 Feb 11.
2022
ASL Asti
AO Ordine Mauriziano

Tucci M; DI Maio M; Scagliotti GV; Pisano C; Samuelly A; Turco F; Bungaro M; Parente A; DI Stefano RF; Angusti T; Buttigliero C;

2022
AO Ordine Mauriziano

Paratore C; Zichi C; Audisio M; Bungaro M; Caglio A; Di Liello R; Gamba T; Gargiulo P; Mariniello A; Reale ML; Perrone F; Di Maio M;

Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab. in International journal of cancer / Int J Cancer. 2022 Aug 1;151(3):473-480. doi: 10.1002/ijc.34033. Epub 2022 Apr 29.
2022
AO Ordine Mauriziano

Ciardiello F; Martinelli E; Di Maio M; Troiani T; Morgillo F; Tuccillo C; Maiello E; Federico A; Loguercio C; Romano M; Gravina AG; Fasano M; Napolitano S; Corte CMD; Esposito L; Famiglietti V; Dallio M; Ciardiello D; Martini G;

Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy. in Cancer communications (London, England) / Cancer Commun (Lond). 2022 Aug;42(8):683-688. doi: 10.1002/cac2.12340. Epub 2022 Jul 22.
2022
ASL Asti
AO Ordine Mauriziano

Scagliotti GV; Ortega C; Di Maio M; Ungaro A; Audisio M; Audisio A; Pisano C; Di Stefano RF; Tucci M; Delcuratolo MD; Turco F; Buttigliero C;

Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM). in ESMO open / ESMO Open. 2022 Aug;7(4):100548. doi: 10.1016/j.esmoop.2022.100548. Epub 2022 Jul 16.
2022
AO Ordine Mauriziano

Pedrazzoli P; Lasagna A; Cassaniti I; Ferrari A; Bergami F; Silvestris N; Sapuppo E; Di Maio M; Cinieri S; Baldanti F;

2022
AO Ordine Mauriziano

Beretta GD; Casolino R; Corsi DC; Perrone F; Di Maio M; Cinieri S; Gobber G; Bellani M; Petrini F; Zocchi MT; Traclò F; Zagonel V;

Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: A systematic review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Apr;172:103649. doi: 10.1016/j.critrevonc.2022.103649. Epub 2022 Mar 5.
2022
AO Ordine Mauriziano

Servetto A; Salomone F; Di Costanzo F; Iuliano R; Marandino L; Napolitano F; Santaniello A; De Placido P; De Placido S; Di Maio M; Formisano L; Bianco R;

Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2022 Apr;71(4):865-874. doi: 10.1007/s00262-021-03045-9. Epub 2021 Aug 31
2022
AO Ordine Mauriziano

Marconcini R; Intagliata S; Audisio M; Lai E; Aprile G; Buti S; Ghidini M; Macrini S; Inno A; Di Marino P; Tuzi A; Nicolardi L; Occhipinti MA; Pergolesi F; Veltri E; Adamo V; Filetti M; Ficorella C; Pantano F; Citarella F; Falcone A; Bossi P; Di Maio M; Scartozzi M; Di Noia V; Calvetti L; Bersanelli M; Grossi F; Gori S; et alii...

Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial. in Frontiers in oncology / Front Oncol. 2022 Sep 15;12:925366. doi: 10.3389/fonc.2022.925366. eCollection 2022.
2022
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano

Giordano M; Di Maio M; Numico G; Rossi M; Gunnellini M; Santini D; Zustovich F; Spinelli GP; Di Pede P; Mariani G; Corsi DC; Fabi A; Velutti L; Berruti A; Coletta D; Sammarco E; Galli L; Miccinesi G; Sbrana A; Roila F; Ripamonti CI; Antonuzzo A; Bossi P;

2022
AO Ordine Mauriziano

D'Angelo V; Piccirillo MC; Di Maio M; Gallo C; Bucci C; Civiletti C; Di Girolamo E; Marone P; Rossi GB; Tempesta AM; Tracey MC; Romano M; Miranda A; Taranto D; Sessa G; Esposito P; Salerno R; Pumpo R; De Filippo FR; Della Valle E; de Bellis M; Perrone F;

Management of Metastatic Endometrial Cancer: Physicians' Choices Beyond the First Line. A MITO Survey. in Frontiers in oncology / Front Oncol. 2022 May 27;12:880008. doi: 10.3389/fonc.2022.880008. eCollection 2022.
2022
AO Ordine Mauriziano

Giannone G; Castaldo D; Tuninetti V; Scotto G; Turinetto M; Valsecchi AA; Bartoletti M; Mammoliti S; Artioli G; Mangili G; Salutari V; Lorusso D; Cormio G; Zamagni C; Savarese A; Di Maio M; Ronzino G; Pisano C; Pignata S; Valabrega G;

Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate. in Prostate cancer and prostatic diseases / Prostate Cancer Prostatic Dis. 2021 Sep;24(3):812-825. doi: 10.1038/s41391-021-00336-1. Epub 2021 Fe
2021
ASL Asti
AO Ordine Mauriziano

Buttigliero C; Di Maio M; Gallicchio M; Scagliotti GV; Vignani F; Pisano C; Bungaro M; Samuelly A; Turco F; Tucci M; Di Stefano RF;

2021
AO Ordine Mauriziano

Cogoni AA; Zagonel V; Del Mastro L; Porta C; Cinieri S; Barberio D; Vaccaro CM; Jommi C; Gitto L; Traclò F; Iannelli E; De Lorenzo F; Del Campo L; Bryce J; Giannarelli D; Frontini L; Montesarchio V; Efficace F; Di Maio M; Arenare L; Riva S; Bordonaro R; Gimigliano A; Piccirillo MC; Guizzaro L; Gallo C; Perrone F;

2021
AO Ordine Mauriziano

Di Bartolomeo M; Morano F; Corallo S; Ratti M; Berenato R; Zaniboni A; Clavarezza M; Murialdo R; Ritorto G; Tampellini M; Amatu A; Smiroldo V; Antoniotti C; Lonardi S; Leone AG; Raimondi A; Fucà G; Di Maio M; Pietrantonio F;

Hurrying up but not rushing, acting and not reacting, good sense and not common sense: Open thoughts and reasonable doubts on COVID-19 vaccination strategies in cancer patients. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Nov;167:103271. doi: 10.1016/j.critrevonc.2021.103271. Epub 2021 Feb 26
2021
AO Ordine Mauriziano

Giusti R; Di Maio M; Loupakis F;

[Early access programs and managed entry agreements for medicines in Italy: results of a Focus Group (Early Access Programs and Managed Entry Agreement).]. in Recenti progressi in medicina / Recenti Prog Med. 2021 Nov;112(11):749-756. doi: 10.1701/3696.36853.
2021
AO Ordine Mauriziano

Marata AM; Langella R; Giuliani G; Gaudioso A; Di Maio M; Caprodossi A; Bordonaro R; Bandello F; Alberti C; Costa F; Armeni P; Jommi C; Patarnello F; Pinto C; Rasi G; Villa F;

2021
AO Ordine Mauriziano

Scagliotti GV; Bussolino F; Righi L; Di Maio M; Passiglia F; Listì A; Caglio A; Tabbò F; Sperone T; Reale ML; Bironzo P; Novello S;

2021
AO Ordine Mauriziano

Gallo C; Di Maio M; Schettino C; Gravina A; Di Liello R; Mancuso G; Morgillo F; Della Corte CM; Esposito G; Spagnuolo A; Palumbo G; Maione P; Gebbia V; Ciardiello F; Morabito A; Gridelli C; Arenare L; Gargiulo P; Perrone F; Piccirillo MC;

Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;149:49-60. doi: 10.1016/j.ejca.2021.03.007. Epub 2021 Apr 3.
2021
AO Ordine Mauriziano

Perrone F; Caglio A; Gamba T; Bungaro M; Audisio M; Reale ML; Mariniello A; Gargiulo P; Zichi C; Paratore C; Di Maio M;

Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;149:153-164. doi: 10.1016/j.ejca.2021.03.010. Epub 2021 Apr 14.
2021
AO Ordine Mauriziano

Peters S; Coukos G; Zimmermann S; Mederos Alfonso NN; Homicsko K; Obeid M; Aglietta M; Valabrega G; Marandino L; Tavazzi E; Gatta R; Pradervand S; Özdemir BC; Caikovski M; Latifyan S; Gautron Moura B; Gérard CL; Imbimbo M; Delyon J; Bouchaab H; Ghisoni E; Wicky A; Cuendet MA; Di Maio M; Michielin O;

Practices and expectations on the use of circulating tumor DNA in colorectal cancer patients: A bi-national AGEO/AIOM/GERCOR/FFCD/FRENCH survey. in Clinics and research in hepatology and gastroenterology / Clin Res Hepatol Gastroenterol. 2021 May;45(3):101681. doi: 10.1016/j.clinre.2021.101681. Epub 2021
2021
AO Ordine Mauriziano

Pernot S; Zaanan A; Lecomte T; Di Maio M; Laurent-Puig P; Lepage C; Aprile G; Goere D; Cohen R; Puglisi F; Gallois C; Basile D; Taieb J;

Post-progression outcomes of NSCLC patients with PD-L1 expression ? 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;148:24-35. doi: 10.1016/j.ejca.2021.02.005. Epub 2021 Mar 12.
2021
AO Ordine Mauriziano

Adamo V; Russo A; Metro G; De Filippis M; Simona C; Natalizio S; Migliorino MR; Landi L; Ricciardi S; Minuti G; Buti S; Nigro O; Cantini L; Russano M; Citarella F; Bracarda S; Zoratto F; Filetti M; Mansueto G; De Tursi M; Gori S; Rocco D; Chiari R; Rastelli F; Targato G; Gelibter A; Signorelli D; Mazzoni F; De Toma A; et alii...

2021
AO Ordine Mauriziano

Lenci E; Cantini L; Pecci F; Cognigni V; Agostinelli V; Mentrasti G; Lupi A; Ranallo N; Paoloni F; Rinaldi S; Nicolardi L; Caglio A; Aerts S; Cortellini A; Ficorella C; Chiari R; Di Maio M; Dingemans AC; Aerts JGJV; Berardi R; Lenci E; Cantini L; Pecci F; Cognigni V; Agostinelli V; Mentrasti G; Lupi A; Ranallo N; Paoloni F; et alii...

2021
AO Ordine Mauriziano

Raimondi A; Olgiati A; Montagna B; Manzoni M; La Verde N; Lasagna A; Grossi F; Giordano M; D'Antonio F; Bernocchi O; Catania G; Balletti E; Zucali PA; Poggi G; Pietrantonio F; Nolè F; Palmeri L; Luciani A; Farina G; Luchena G; Borgonovo K; Bernardo A; Agustoni F; Giudici F; Tagliaferri B; Generali D; Di Cosimo S; Rampinelli I; Verri E; et alii...

Synaptophysin expression in (V600EBRAF-)mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Mar;146:145-154. doi: 10.1016/j.ejca.2021.01.016. Epub 2021 Feb 16.
2021
AO Ordine Mauriziano

Borga C; Biason P; Centonze G; Salmaso R; Salvatore L; Santini D; Aprile G; Calvetti L; Smiroldo V; Rimassa L; De Maglio G; Cortiula F; Morano F; Volante M; Boccaccino A; Bergamo F; Zichi C; Sperti E; Dell'Aquila E; Pella N; Pietrantonio F; Schirripa M; Cremolini C; Maddalena G; Milione M; Fassan M; Lonardi S; Zagonel V; Dei Tos AP; et alii...

2021
AO Ordine Mauriziano

Raimondi A; Palermo F; Prisciandaro M; Aglietta M; Antonuzzo L; Aprile G; Berardi R; Cardellino GG; De Manzoni G; De Vita F; Di Maio M; Fornaro L; Frassineti GL; Granetto C; Iachetta F; Lonardi S; Murialdo R; Ongaro E; Pucci F; Ratti M; Silvestris N; Smiroldo V; Spallanzani A; Strippoli A; Tamberi S; Tamburini E; Zaniboni A; Di Bartolomeo M; Cremolini C; et alii...

Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC. in Endocrine-related cancer / Endocr Relat Cancer. 2021 Jun 2;28(7):R207-R216. doi: 10.1530/ERC-20-0457.
2021
ASL Asti
AO Ordine Mauriziano

Buttigliero C; Scagliotti GV; Di Maio M; Pisano C; Bungaro M; Audisio M; Samuelly A; Tucci M; Di Stefano RF; Turco F;

A qualitative analysis and development of a conceptual model assessing financial toxicity in cancer patients accessing the universal healthcare system. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2021 Jun;29(6):3219-3233. doi: 10.1007/s00520-020-05840-z. Epub 2020 Oct 22.
2021
AO Ordine Mauriziano

Piccirillo MC; Sparavigna L; Savio A; Romano F; Gimigliano A; Canzanella G; Arenare L; Vaccaro CM; Traclò F; Montesarchio V; Jommi C; Iannelli E; Gitto L; Giannarelli D; Frontini L; De Lorenzo F; Bryce J; Del Campo L; Di Maio M; Riva S; Efficace F; Guizzaro L; Gallo C; Perrone F;

Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jun;10(6):2890-2916. doi: 10.21037/tlcr-20-941.
2021
AO Ordine Mauriziano

Facchinetti F; Di Maio M; Friboulet L; Tiseo M; Guaitoli G;

Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Jun;150:224-231. doi: 10.1016/j.ejca.2021.03.041. Epub 2021 May 3.
2021
AO Ordine Mauriziano

Addeo A; Banna GL; Spinelli GP; Russo A; Adamo V; Metro G; Olmetto E; Tabbò F; Ricciardi S; Migliorino MR; Minuti G; Landi L; Bisonni R; Tuzi A; Follador A; Siringo M; Gelibter A; Signorelli D; De Toma A; Garassino MC; Russano M; Mazzoni F; Citarella F; Filetti M; Zoratto F; Mansueto G; Di Marino P; De Tursi M; Gori S; et alii...

First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysis. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jun;10(6):2917-2936. doi: 10.21037/tlcr-21-15.
2021
AO Ordine Mauriziano

Perrone F; Di Maio M; Facchinetti F; Tiseo M;

Heterogeneity of treatment effects in malignant pleural mesothelioma. in Lancet (London, England) / Lancet. 2021 Jul 24;398(10297):301-302. doi: 10.1016/S0140-6736(21)00882-5.
2021
AO Ordine Mauriziano

Tagliamento M; Di Maio M;

Preadmission Statin Therapy and Clinical Outcome in Hospitalized Patients With COVID-19: An Italian Multicenter Observational Study. in Journal of cardiovascular pharmacology / J Cardiovasc Pharmacol. 2021 Jul 1;78(1):e94-e100. doi: 10.1097/FJC.0000000000001041.
2021
ASL Torino 3
AO Ordine Mauriziano

Albani S; Musumeci G; Varbella F; Celentani D; Parodi G; Nunziata L; D'Andrea A; Attena E; Scudiero F; Silverio A; Russo V; Di Micco P; Di Maio M; Russo V; Silverio A; Scudiero F; Attena E; D'Andrea A; Nunziata L; Parodi G; Celentani D; Varbella F; Albani S; Musumeci G; Di Micco P; Di Maio M;

Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature. in Gynecologic oncology / Gynecol Oncol. 2021 Jul;162(1):80-87. doi: 10.1016/j.ygyno.2021.04.018. Epub 2021 Apr 22.
2021
ASL VCO
AO Ordine Mauriziano

Valabrega G; Aglietta M; Pasini B; Di Maio M; Zavallone L; Gemmiti S; Turinetto M; Mittica G; Ghisoni E; Villa M; Tuninetti V; Mangiacotti S; Cosma S; Ferrero A; Borella F; Farolfi A; Katsaros D; De Giorgi U; Scotto G; Giannone G;

A narrative review of primary research endpoints of neoadjuvant therapy for lung cancer: past, present and future. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jul;10(7):3264-3275. doi: 10.21037/tlcr-21-259.
2021
AO Ordine Mauriziano

Guibert N; Rossi A; Hida T; Califano R; Di Maio M; Camidge DR; Lin Y; Xu A; Ren S; Zhu C; Shen J;

Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Jan;157:103185. doi: 10.1016/j.critrevonc.2020.103185. Epub 2020 Nov 27
2021
ASL Asti
AO Ordine Mauriziano

Di Maio M; Buttigliero C; Scagliotti GV; Turco F; Di Stefano RF; Tucci M; Pisano C;

Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET Study. in Cancers / Cancers (Basel). 2021 Dec 23;14(1):69. doi: 10.3390/cancers14010069.
2021
AO Ordine Mauriziano

Truong Thanh XM; Regnault B; Milione M; Di Bartolomeo M; Buzzoni R; Coppa J; Corti F; Torchio M; Prinzi N; Di Maio M; Vernieri C; Pusceddu S; Mazzaferro V; de Braud F;

Equity in Drug Accessibility: The Surprising Case of Treatments for Metastatic Castration-sensitive Prostate Cancer in European Countries. in European urology oncology / Eur Urol Oncol. 2021 Dec;4(6):1011-1012. doi: 10.1016/j.euo.2021.08.002. Epub 2021 Sep 15.
2021
AO Ordine Mauriziano

Di Maio M; Caffo O;

2021
AO Ordine Mauriziano

Mariniello A; Bironzo P; Pisano C; De Filippis M; Persano I; Olmetto E; Caramello V; Boccuzzi A; Capelletto E; Passiglia F; Di Maio M; Novello S; Mariniello A; Bironzo P; Pisano C; De Filippis M; Persano I; Olmetto E; Caramello V; Boccuzzi A; Capelletto E; Passiglia F; Di Maio M; Novello S;

Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide. in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):803-814. doi: 10.23736/S2724-6051.21.04186-2. Epub 2021 Mar 29.
2021
ASL Asti
AO Ordine Mauriziano

Buttigliero C; DI Maio M; Scagliotti GV; Tarenghi F; Bungaro M; Vignani F; Samuelly A; Turco F; DI Stefano RF; Tucci M; Pisano C;

Second medical opinion in oncological setting. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Apr;160:103282. doi: 10.1016/j.critrevonc.2021.103282. Epub 2021 Mar 3.
2021
AO Ordine Mauriziano

Cinieri S; Comandone A; Bordonaro R; Beretta G; Perrone F; Lanzetta G; Galvano A; Zagonel V; Di Maio M; Gonzato O; Scagnoli S; Marchetti P; Russo A; La Verde N; Maruzzo M; Nicolis F; Gori S;

2021
AO Ordine Mauriziano

Bironzo P; Metro G; Passiglia F; Migliorino MR; Ricciardi S; Landi L; Minuti G; Bordi P; Tuzi A; Cantini L; Russano M; Citarella F; Santini D; Filetti M; Zoratto F; Mansueto G; Di Marino P; Grassadonia A; Michele T; Inno A; Della Gravara L; Rocco D; Chiari R; Rastelli F; Macerelli M; Marchetti P; Siringo M; Gelibter A; Signorelli D; et alii...

2021
ASL Asti
AO Ordine Mauriziano

Beretta GD; Cinieri S; Tucci M; Perrone F; La Verde N; Del Mastro L; Giuffrida D; De Giorgi U; Chiari R; Russo A; Di Maio M; Silvestris N;

A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step? in Exploration of targeted anti-tumor therapy / Explor Target Antitumor Ther. 2021;2(5):448-464. doi: 10.37349/etat.2021.00056. Epub 2021 Oct 31.
2021
AO Ordine Mauriziano

Di Maio M; De Vita F; Gamba T; Caglio A; Sperti E; Marino D; Zichi C; Paratore C; Aimar G;

2020
ASL Asti
AO Ordine Mauriziano

Tucci M; Necchi A; Gamba T; Buttigliero C; Vignani F; Marandino L; Di Maio M;

2020
AO Ordine Mauriziano

Facchinetti F; Di Maio M; Tiseo M;

Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak. in European journal of clinical investigation / Eur J Clin Invest. 2020 Sep;50(9):e13315. doi: 10.1111/eci.13315. Epub 2020 Jul 5.
2020
AO Ordine Mauriziano

Tagliamento M; Spagnolo F; Poggio F; Soldato D; Conte B; Ruelle T; Barisione E; De Maria A; Del Mastro L; Di Maio M; Lambertini M;

DiM: Prognostic Score for Second- or Further-line Immunotherapy in Advanced Non-Small-Cell Lung Cancer: An External Validation. in Clinical lung cancer / Clin Lung Cancer. 2020 Sep;21(5):e337-e348. doi: 10.1016/j.cllc.2020.01.005. Epub 2020 Mar 7.
2020
AO Ordine Mauriziano

Prelaj A; Lo Russo G; Proto C; Signorelli D; Ferrara R; Galli G; De Toma A; Randon G; Pagani F; Trevisan B; Ganzinelli M; Zilembo N; Montrone M; Longo V; Pesola F; Pizzutilo P; Del Bene G; Varesano N; Galetta D; Torri V; Garassino MC; Di Maio M; Catino A;

Prospective Translational Study Investigating Molecular PrEdictors of Resistance to First-Line PazopanIb in Metastatic reNal CEll Carcinoma (PIPELINE Study). in American journal of clinical oncology / Am J Clin Oncol. 2020 Sep;43(9):621-627. doi: 10.1097/COC.0000000000000719.
2020
AO Ordine Mauriziano

Sepe P; Martinetti A; Mennitto A; Verzoni E; Claps M; Raimondi A; Sottotetti E; Grassi P; Guadalupi V; Stellato M; Zattarin E; Di Maio M; Procopio G;

2020
AO Ordine Mauriziano

Orlando L; Lorusso V; Giotta F; Di Maio M; Schiavone P; Fedele P; Quaranta A; Caliolo C; Ciccarese M; Cinefra M; Romito S; Pisconti S; Prete SD; Aieta M; Rizzi D; Maiello E; Colucci G; Cinieri S;

[Outcomes reported by the patient: a tool for respecting the patient's rights and for involvement in research.]. in Recenti progressi in medicina / Recenti Prog Med. 2020 Nov;111(11):685-689. doi: 10.1701/3474.34575.
2020
AO Ordine Mauriziano

Di Maio M;

Assessing the Impact of the COVID-19 Outbreak on the Attitudes and Practice of Italian Oncologists Toward Breast Cancer Care and Related Research Activities. in JCO oncology practice / JCO Oncol Pract. 2020 Nov;16(11):e1304-e1314. doi: 10.1200/OP.20.00297. Epub 2020 Jun 23.
2020
AO Ordine Mauriziano

Poggio F; Tagliamento M; Di Maio M; Martelli V; De Maria A; Barisione E; Grosso M; Boccardo F; Pronzato P; Del Mastro L; Lambertini M;

Real-World Evidence in Oncology: Opportunities and Limitations. in The oncologist / Oncologist. 2020 May;25(5):e746-e752. doi: 10.1634/theoncologist.2019-0647. Epub 2019 Dec 24.
2020
AO Ordine Mauriziano

Conte P; Di Maio M; Perrone F;

Quality of life in patients with lung cancer: the way forward. in The Lancet. Oncology / Lancet Oncol. 2020 May;21(5):617-619. doi: 10.1016/S1470-2045(20)30151-0. Epub 2020 Mar 23.
2020
AO Ordine Mauriziano

Reale ML; Di Maio M;

First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 May;130:155-167. doi: 10.1016/j.ejca.2020.02.023. Epub 2020 Mar 25.
2020
AO Ordine Mauriziano

Facchinetti F; Mazzaschi G; Barbieri F; Passiglia F; Mazzoni F; Berardi R; Proto C; Cecere FL; Pilotto S; Scotti V; Rossi S; Del Conte A; Vita E; Bennati C; Ardizzoni A; Cerea G; Migliorino MR; Sala E; Camerini A; Bearz A; De Carlo E; Zanelli F; Guaitoli G; Garassino MC; Ciccone LP; Sartori G; Toschi L; Dall'Olio FG; Landi L; et alii...

Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2020 Mar 1;26(5):1017-1024. doi: 10.1158/1078-0432.CCR-19-3024. Epub 2019 Nov 18.
2020
AO Ordine Mauriziano

Milione M; Di Nicolantonio F; Tamborini E; Perrone F; Barault L; Macagno M; Martinetti A; Palermo F; Guarini V; Pagani F; Corallo S; Randon G; Gori S; Petrelli F; Farina G; Longarini R; Tomasello G; Sartore-Bianchi A; Murgioni S; Rimassa L; Mosconi S; Morano F; Raimondi A; Lonardi S; Antista M; Lobefaro R; Pietrantonio F; Di Maio M; Fucà G; et alii...

Carcinoid heart failure in a duodenal neuroendocrine tumor: role of cardiac surgery in a challenging patient and brief review of the literature. in Acta oncologica (Stockholm, Sweden) / Acta Oncol. 2020 Mar;59(3):315-319. doi: 10.1080/0284186X.2019.1672891. Epub 2019 Oct 4.
2020
AO Ordine Mauriziano

Scagliotti GV; Atzeni F; Di Maio M; Muratori L; Parisi F; Trevisi E; Brizzi MP; La Salvia A;

[Could a medication management app help people to optimize their oral cancer drugs intake?]. in Recenti progressi in medicina / Recenti Prog Med. 2020 Mar;111(3):125-126. doi: 10.1701/3315.32851.
2020
AO Ordine Mauriziano

Di Maio M;

Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective. in ESMO open / ESMO Open. 2020 Mar;5(2):e000759. doi: 10.1136/esmoopen-2020-000759.
2020
AO Ordine Mauriziano

Lambertini M; Toss A; Passaro A; Criscitiello C; Cremolini C; Cardone C; Loupakis F; Viscardi G; Meattini I; Dieci MV; Ferrara R; Giusti R; Di Maio M;

Bone health management in the continuum of prostate cancer disease: a review of the evidence with an expert panel opinion. in ESMO open / ESMO Open. 2020 Mar;5(2):e000652. doi: 10.1136/esmoopen-2019-000652.
2020
AO Ordine Mauriziano

Santini D; Berruti A; Di Maio M; Procopio G; Bracarda S; Ibrahim T; Bertoldo F;

Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study. in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico / Clin Transl Oncol. 2020 Mar;22(3):294-301. doi: 10.1007/s12094-019-02222-8. Epub 2019 Oct 19.
2020
AO Ordine Mauriziano

Gobbini E; Chiari R; Pizzutillo P; Bordi P; Ghilardi L; Pilotto S; Osman G; Cappuzzo F; Cecere F; Riccardi F; Scotti V; Martelli O; Borra G; Maiello E; Rossi A; Graziano P; Gregorc V; Casartelli C; Sergi C; Del Conte A; Delmonte A; Bareggi C; Cortinovis D; Rizzo P; Tabbò F; Rossi G; Bria E; Galetta D; Tiseo M; et alii...

The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer. in Liver international : official journal of the International Association for the Study of the Liver / Liver Int. 2020 Mar;40(3):704-711. doi: 10.1111/liv.14314. Epub 2019 Dec 11.
2020
AO Ordine Mauriziano

Aprile G; Silvestris N; Santini D; Gelsomino F; Spallanzani A; Depetris I; Cagnazzo C; Lombardi P; Fenocchio E; Ortega C; Di Maio M; Sperti E; Fornaro L; Aglietta M; Cerma K; Salani F; Leone F; Vivaldi C; Caputo F; Filippi R; Salati M; Roviello G; Scartozzi M; Cascinu S; Casadei-Gardini A;

The Use of Not-Negative Conclusions to Describe Results of Formally Negative Trials Presented at Oncology Meetings. in JAMA oncology / JAMA Oncol. 2020 Jun 1;6(6):926-927. doi: 10.1001/jamaoncol.2020.0475.
2020
AO Ordine Mauriziano

Di Maio M; Audisio M; Cardone C; De Luca E; Gargiulo P; Zichi C; Perrone F;

2020
AO Ordine Mauriziano

Maiello E; Di Maggio G; Cordio S; Cinieri S; Giuliani F; Pisconti S; Rinaldi A; Febbraro A; Latiano TP; Aieta M; Rossi A; Rizzi D; Di Maio M; Colucci G; Bordonaro R;

2020
AO Ordine Mauriziano

Antonuzzo A; Calabrò F; Quaglino P; Roila F; Sebastiani GD; Spina F; Pasqualetti G; Cortinovis D; Tagliaferri E; Peri A; Presotto EM; Egidi MF; Giacomelli L; Farroni F; Di Maio M; De Luca E; Danova M; Scottè F; Jordan K; Bossi P;

Neuroendocrine breast carcinoma: a rare but challenging entity. in Medical oncology (Northwood, London, England) / Med Oncol. 2020 Jul 25;37(8):70. doi: 10.1007/s12032-020-01396-4.
2020
AO Ordine Mauriziano

Trevisi E; La Salvia A; Daniele L; Brizzi MP; De Rosa G; Scagliotti GV; Di Maio M;

Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Jan;139:47-54. doi: 10.1016/j.lungcan.2019.10.022. Epub 2019 Oct 31.
2020
AO Ordine Mauriziano

Novello S; Aglietta M; Bironzo P; Sonetto C; La Salvia A; Muratori L; Leone G; Trevisi E; Mariniello A; Di Stefano RF; Ghisoni E; Pignataro D; Zichi C; Marandino L; Lombardi P; De Luca E; Reale ML; Scagliotti GV; Perrone F; Di Maio M;

Impact of primary tumor location on patterns of recurrence and survival of patients undergoing resection of liver metastases from colon cancer. in HPB : the official journal of the International Hepato Pancreato Biliary Association / HPB (Oxford). 2020 Jan;22(1):116-123. doi: 10.1016/j.hpb.2019.05.014. Epub 2019 Jun 22.
2020
AO Ordine Mauriziano

Russolillo N; Sperti E; Langella S; Menonna F; Allieta A; Di Maio M; Ferrero A; Russolillo N; Sperti E; Langella S; Menonna F; Allieta A; Di Maio M; Ferrero A;

Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Feb;146:102877. doi: 10.1016/j.critrevonc.2020.102877. Epub 2020 Jan 18
2020
AO Ordine Mauriziano

Lombardi P; Marandino L; De Luca E; Zichi C; Reale ML; Pignataro D; Di Stefano RF; Ghisoni E; Mariniello A; Trevisi E; Leone G; Muratori L; La Salvia A; Sonetto C; Leone F; Aglietta M; Novello S; Scagliotti GV; Perrone F; Di Maio M;

Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study. in Immunotherapy / Immunotherapy. 2020 Feb;12(2):151-159. doi: 10.2217/imt-2019-0180.
2020
AO Ordine Mauriziano

Bersanelli M; Buti S; Banna GL; De Giorgi U; Cortellini A; Rebuzzi SE; Tiseo M; Fornarini G; Mazzoni F; Panni S; De Tursi M; Di Marino P; Rossetti S; Rossi E; Tomao S; De Luca E; Sorarù M; Mucciarini C; Atzori F; La Torre L; Vitale MG; Martelli V; Sepe P; Mollica V; Vaccaro V; Schinzari G; Ficorella C; Massari F; Maestri A; et alii...

Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2020 Dec;9(6):2696-2715. doi: 10.21037/tlcr-2020-63.
2020
AO Ordine Mauriziano

Liang W; Cai K; Chen C; Chen H; Chen Q; Fu J; Hu J; Jiang T; Jiao W; Li S; Liu C; Liu D; Liu W; Liu Y; Ma H; Pan X; Qiao G; Tian H; Wei L; Zhang Y; Zhao S; Zhao X; Zhou C; Zhu Y; Zhong R; Li F; Rosell R; Provencio M; Massarelli E; et alii...

Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2020 Dec;72(6):737-745. doi: 10.23736/S0393-2249.20.03708-X. Epub 2020 Apr 10.
2020
AOU Alessandria
AO Ordine Mauriziano

Numico G; Scagliotti GV; Guglielmini P; Lacidogna G; Turco F; Pisano C; Di Stefano RF; Vignani F; Sonetto C; Tucci M; Buttigliero C; Di Maio M;

Impact of adoption of patient-reported outcomes in clinical practice on the accuracy of symptom reporting in medical records of cancer patients. in Recenti progressi in medicina / Recenti Prog Med. 2020 Dec;111(12):740-748. doi: 10.1701/3509.34965.
2020
AO Ordine Mauriziano

Marino D; Baratelli C; Guida G; Turco CGC; Lacidogna G; Sperti E; Vignani F; De Luca E; Zichi C; Audisio M; Ballaminut D; Bellezza A; Chiotto P; Ciriolo G; Comite R; Codegone F; Florio S; Fusco L; Polimeno L; Pozzi D; Zilio E; Terzolo S; Di Maio M;

Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Dec;150:123-131. doi: 10.1016/j.lungcan.2020.10.008. Epub 2020 Oct 22.
2020
AO Ordine Mauriziano

Bersanelli M; Buti S; Giannarelli D; Leonetti A; Cortellini A; Russo GL; Signorelli D; Toschi L; Milella M; Pilotto S; Bria E; Proto C; Marinello A; Randon G; Rossi S; Vita E; Sartori G; D'Argento E; Qako E; Giaiacopi E; Ghilardi L; Bettini AC; Rapacchi E; Mazzoni F; Lavacchi D; Scotti V; Ciccone LP; De Tursi M; Di Marino P; et alii...

Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2020 Aug 20:JCO2001225. doi: 10.1200/JCO.20.01225.
2020
AO Ordine Mauriziano

Cremolini C; Antoniotti C; Stein A; Bendell J; Gruenberger T; Rossini D; Masi G; Ongaro E; Hurwitz H; Falcone A; Schmoll HJ; Di Maio M;

2020
AO Ordine Mauriziano

Tuninetti V; Di Napoli M; Ghisoni E; Maggiorotto F; Robella M; Scotto G; Giannone G; Turinetto M; Siatis D; Ponzone R; Vaira M; De Simone M; Scaffa C; Pignata S; Greggi S; Di Maio M; Valabrega G;

Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Aug;152:102994. doi: 10.1016/j.critrevonc.2020.102994. Epub 2020 May 24
2020
ASL Asti
AO Ordine Mauriziano

Di Maio M; Scagliotti GV; Vignani F; Turco F; Tabbò F; Di Stefano RF; Pisano C; Buttigliero C; Leone G; Tucci M;

The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer. in The oncologist / Oncologist. 2020 Aug;25(8):661-668. doi: 10.1634/theoncologist.2019-0780. Epub 2020 Mar 23.
2020
AO Ordine Mauriziano

Basile D; Garattini SK; Corvaja C; Montico M; Cortiula F; Pelizzari G; Gerratana L; Audisio M; Lisanti C; Fanotto V; Ongaro E; Iacono D; Cardellino GG; Foltran L; Pella N; Buonadonna A; Aprile G; Di Maio M; Fasola G; Puglisi F;

Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Aug;135:230-239. doi: 10.1016/j.ejca.2020.04.048. Epub 2020 Jul 2.
2020
AO Ordine Mauriziano

Raimondi A; Di Maio M; Morano F; Corallo S; Lonardi S; Antoniotti C; Rimassa L; Sartore-Bianchi A; Tampellini M; Ritorto G; Murialdo R; Clavarezza M; Zaniboni A; Adamo V; Tomasello G; Petrelli F; Antonuzzo L; Giordano M; Cinieri S; Longarini R; Bergamo F; Niger M; Antista M; Peverelli G; de Braud F; Di Bartolomeo M; Pietrantonio F;

The KEY for chemo-immunotherapy combination: taking NOTEs from squamous cell lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2020 Apr;9(2):410-413. doi: 10.21037/tlcr.2020.02.02.
2020
AO Ordine Mauriziano

Reale ML; De Luca E; Di Maio M;

Ramucirumab, A Second-Line Option For Patients With Hepatocellular Carcinoma: A Review Of The Evidence. in Cancer management and research / Cancer Manag Res. 2020 May 20;12:3721-3729. doi: 10.2147/CMAR.S216220. eCollection 2020.
2020
AO Ordine Mauriziano

De Luca E; Marino D; Di Maio M;

Coronavirus: Older Persons With Cancer in Italy in the COVID-19 Pandemic. in Frontiers in oncology / Front Oncol. 2020 Apr 30;10:648. doi: 10.3389/fonc.2020.00648. eCollection 2020.
2020
AO Ordine Mauriziano

Fratino L; Procopio G; Di Maio M; Cinieri S; Leo S; Beretta G;

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG. in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2020 Nov 2;12:1758835920968463. doi: 10.1177/1758835920968463. eCollection 2020.
2020
AO Ordine Mauriziano

Pignata S; De Giorgi U; Giannarelli D; Bersanelli M; Di Maio M; Verzoni E; Clemente A; Guadalupi V; Signorelli D; Tiseo M; Giusti R; Filetti M; Di Napoli M; Calvetti L; Cappetta A; Ermacora P; Zara D; Barbieri F; Baldessari C; Scotti V; Mazzoni F; Veccia A; Guglielmini PF; Maruzzo M; Rossi E; Grossi F; Casadei C; Cortellini A; Verderame F; et alii...

2019
AO Ordine Mauriziano

Riva S; Bryce J; De Lorenzo F; Del Campo L; Di Maio M; Efficace F; Frontini L; Giannarelli D; Gitto L; Iannelli E; Jommi C; Montesarchio V; Traclò F; Vaccaro CM; Gallo C; Perrone F;

A validated prognostic classifier for (V600E)BRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2019 Sep;118:121-130. doi: 10.1016/j.ejca.2019.06.008. Epub 2019 Jul 19.
2019
AO Ordine Mauriziano

Loupakis F; Intini R; Cremolini C; Orlandi A; Sartore-Bianchi A; Pietrantonio F; Pella N; Spallanzani A; Dell'Aquila E; Scartozzi M; De Luca E; Rimassa L; Formica V; Leone F; Calvetti L; Aprile G; Antonuzzo L; Urbano F; Prenen H; Negri F; Di Donato S; Buonandi P; Tomasello G; Avallone A; Zustovich F; Moretto R; Antoniotti C; Salvatore L; Calegari MA; et alii...

Bone-targeted therapy in castration-resistant prostate cancer: where do we stand? in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2019 Oct;71(5):445-456. doi: 10.23736/S0393-2249.19.03420-9. Epub 2019 Jul 25.
2019
AO Ordine Mauriziano

Gómez Rivas J; Carrion DM; Alvarez-Maestro M; Cathelineau X; Sanchez-Salas R; Di Lorenzo G; Di Maio M; Paul A; Martinez-Piñeiro L; Sartor O; Saad F; Debruyne F;

Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2019 Oct;17(5):332-347.e2. doi: 10.1016/j.clgc.2019.07.007. Epub 2019 Jul 20
2019
AO Ordine Mauriziano

Marandino L; De Luca E; Zichi C; Lombardi P; Reale ML; Pignataro D; Di Stefano RF; Ghisoni E; Mariniello A; Trevisi E; Leone G; Muratori L; La Salvia A; Sonetto C; Buttigliero C; Tucci M; Aglietta M; Novello S; Scagliotti GV; Perrone F; Di Maio M;

CK7 and consensus molecular subtypes as major prognosticators in (V600E)BRAF mutated metastatic colorectal cancer. in British journal of cancer / Br J Cancer. 2019 Oct;121(7):593-599. doi: 10.1038/s41416-019-0560-0. Epub 2019 Sep 2.
2019
AO Ordine Mauriziano

Loupakis F; Biason P; Prete AA; Cremolini C; Pietrantonio F; Pella N; Dell'Aquila E; Sperti E; Zichi C; Intini R; Dadduzio V; Schirripa M; Bergamo F; Antoniotti C; Morano F; Cortiula F; De Maglio G; Rimassa L; Smiroldo V; Calvetti L; Aprile G; Salvatore L; Santini D; Munari G; Salmaso R; Guzzardo V; Mescoli C; Lonardi S; Rugge M; et alii...

Women With Synchronous or Metachronous Lung and Ovarian Cancer: A Multi-Institutional Report. in In vivo (Athens, Greece) / In Vivo. 2019 Nov-Dec;33(6):2021-2026. doi: 10.21873/invivo.11699.
2019
AO Ordine Mauriziano

Mariniello A; Ghisoni E; Righi L; Catino A; Chiari R; Del Conte A; Barbieri F; Cecere F; Gelibter A; Giajlevra M; Parra HS; Zichi C; DI Maio M; Valabrega G; Novello S;

Prophylactic cranial irradiation in extensive disease small cell lung cancer: An endless debate. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2019 Nov;143:95-101. doi: 10.1016/j.critrevonc.2019.08.010. Epub 2019 Sep 12
2019
AO Ordine Mauriziano

Picardi C; Caparroti F; Di Maio M; Kaššák F; Banna GL; Addeo A;

Effects of KEAP1 Silencing on the Regulation of NRF2 Activity in Neuroendocrine Lung Tumors. in International journal of molecular sciences / Int J Mol Sci. 2019 May 23;20(10):2531. doi: 10.3390/ijms20102531.
2019
AO Ordine Mauriziano

Sparaneo A; Fabrizio FP; la Torre A; Graziano P; Di Maio M; Fontana A; Bisceglia M; Rossi A; Pizzolitto S; De Maglio G; Tancredi A; Grimaldi F; Balsamo T; Centra F; Manzorra MC; Trombetta D; Pantalone A; Bonfitto A; Maiello E; Fazio VM; Muscarella LA;

Knowledge, attitudes and practice of physicians towards fertility and pregnancy-related issues in youngBRCA-mutated breast cancer patients. in Reproductive biomedicine online / Reprod Biomed Online. 2019 May;38(5):835-844. doi: 10.1016/j.rbmo.2018.11.031. Epub 2019 Jan 10.
2019
AO Ordine Mauriziano

Lambertini M; Di Maio M; Poggio F; Pagani O; Curigliano G; Mastro LD; Paluch-Shimon S; Loibl S; Partridge AH; Azim HA Jr; Peccatori FA; Demeestere I;

Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era. in Cancer treatment reviews / Cancer Treat Rev. 2019 Mar;74:35-42. doi: 10.1016/j.ctrv.2019.01.002. Epub 2019 Jan 7.
2019
AO Ordine Mauriziano

Tucci M; Caffo O; Buttigliero C; Cavaliere C; D'aniello C; Di Maio M; Kinspergher S; Maines F; Rizzo M; Rossetti S; Veccia A; Scagliotti GV; Facchini G;

[Description of adverse events in publications of clinical trials: much room for improvement.]. in Recenti progressi in medicina / Recenti Prog Med. 2019 Jul-Aug;110(7):323-324. doi: 10.1701/3197.31742.
2019
AO Ordine Mauriziano

Di Maio M; Antonuzzo A; Bossi P;

State of the art about influenza vaccination for advanced cancer patients receiving immune checkpoint inhibitors: When common sense is not enough. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2019 Jul;139:87-90. doi: 10.1016/j.critrevonc.2019.05.003. Epub 2019 May 8.
2019
AO Ordine Mauriziano

Bersanelli M; Buti S; De Giorgi U; Di Maio M; Giannarelli D; Pignata S; Banna GL;

Systematic Review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy. in Future oncology (London, England) / Future Oncol. 2019 Jul;15(21):2543-2553. doi: 10.2217/fon-2018-0772. Epub 2019 Jun 26.
2019
AO Ordine Mauriziano

Bossi P; Botta L; Bironzo P; Sonetto C; Musettini G; Sbrana A; Di Giannantonio V; Locati LD; Di Maio M; Antonuzzo A;

The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients' quality of life. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2019 Dec;27(12):4697-4704. doi: 10.1007/s00520-019-04777-2. Epub 2019 Apr 4.
2019
AO Ordine Mauriziano

Baratelli C; Turco CGC; Lacidogna G; Sperti E; Vignani F; Marino D; Zichi C; De Luca E; Audisio M; Ballaminut D; Bellezza A; Chiotto P; Ciriolo G; Comite R; Codegone F; Florio S; Fusco L; Polimeno L; Pozzi D; Zilio E; Terzolo S; Di Maio M;

Reply to the letter to the editor 'On the underreporting of health-related quality of life and regulatory approval' by Bhamidipati et al. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2019 Apr 1;30(4):658-659. doi: 10.1093/annonc/mdz035.
2019
AO Ordine Mauriziano

Di Maio M; Marandino L; Perrone F;

Second-line treatment options in hepatocellular carcinoma. in Drugs in context / Drugs Context. 2019 Apr 10;8:212577. doi: 10.7573/dic.212577. eCollection 2019.
2019
AO Ordine Mauriziano

Marino D; Zichi C; Audisio M; Sperti E; Di Maio M;

2019
AO Ordine Mauriziano

Addeo A; Banna GL; Metro G; Di Maio M;

Capecitabine plus temozolomide in well- or moderately-differentiated primary atypical neuroendocrine tumours - single-centre experience of two cases. in Endokrynologia Polska / Endokrynol Pol. 2019;70(4):380-383. doi: 10.5603/EP.a2018.0076. Epub 2018 Oct 25.
2019
AO Ordine Mauriziano

La Salvia A; Brizzi MP; Muratori L; Trevisi E; Di Maio M; Scagliotti GV;

2018
AO Ordine Mauriziano

Passiglia F; Rizzo S; Di Maio M; Galvano A; Badalamenti G; Listì A; Gulotta L; Castiglia M; Fulfaro F; Bazan V; Russo A;

Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer? in Translational lung cancer research / Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S294-S296. doi: 10.21037/tlcr.2018.07.12.
2018
AO Ordine Mauriziano

Metro G; Di Maio M;

Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer? in Translational lung cancer research / Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S290-S293. doi: 10.21037/tlcr.2018.07.11.
2018
AO Ordine Mauriziano

Metro G; Di Maio M;

Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences. in Cancer treatment reviews / Cancer Treat Rev. 2018 Sep;69:215-223. doi: 10.1016/j.ctrv.2018.07.010. Epub 2018 Jul 20.
2018
AO Ordine Mauriziano

Buttigliero C; Allis S; Tucci M; Zichi C; Leone G; Di Stefano RF; Ruo Redda MG; Ricardi U; Scagliotti GV; Di Maio M; Filippi AR;

Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Sep;129:124-132. doi: 10.1016/j.critrevonc.2018.07.004. Epub 2018 Jul 1
2018
AO Ordine Mauriziano

Di Nunno V; De Luca E; Buttigliero C; Tucci M; Vignani F; Gatto L; Zichi C; Ardizzoni A; Di Maio M; Massari F;

Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Sep;129:54-66. doi: 10.1016/j.critrevonc.2018.06.011. Epub 2018 Jun 21.
2018
AO Ordine Mauriziano

Trestini I; Carbognin L; Monteverdi S; Zanelli S; De Toma A; Bonaiuto C; Nortilli R; Fiorio E; Pilotto S; Di Maio M; Gasbarrini A; Scambia G; Tortora G; Bria E;

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. in Immunotherapy / Immunotherapy. 2018 Oct;10(14):1229-1239. doi: 10.2217/imt-2018-0080.
2018
AO Ordine Mauriziano

Bersanelli M; Giannarelli D; Castrignanò P; Fornarini G; Panni S; Mazzoni F; Tiseo M; Rossetti S; Gambale E; Rossi E; Papa A; Cortellini A; Lolli C; Ratta R; Michiara M; Milella M; De Luca E; Sorarù M; Mucciarini C; Atzori F; Banna GL; La Torre L; Vitale MG; Massari F; Rebuzzi SE; Facchini G; Schinzari G; Tomao S; Bui S; et alii...

2018
AO Ordine Mauriziano

Passiglia F; Rizzo S; Di Maio M; Galvano A; Badalamenti G; Listì A; Gulotta L; Castiglia M; Fulfaro F; Bazan V; Russo A;

A review of guidelines for lung cancer. in Journal of thoracic disease / J Thorac Dis. 2018 May;10(Suppl 13):S1556-S1563. doi: 10.21037/jtd.2018.03.54.
2018
AO Ordine Mauriziano

Bironzo P; Di Maio M;

Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer. in Clinical lung cancer / Clin Lung Cancer. 2018 Mar;19(2):191-198. doi: 10.1016/j.cllc.2017.10.012. Epub 2017 Oct 28.
2018
AO Ordine Mauriziano

Gobbini E; Pilotto S; Pasello G; Polo V; Di Maio M; Arizio F; Galetta D; Petrillo P; Chiari R; Matocci R; Di Costanzo A; Di Stefano TS; Aglietta M; Cagnazzo C; Sperduti I; Bria E; Novello S;

Loss of C/EBP-? LIP drives cisplatin resistance in malignant pleural mesothelioma. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2018 Jun;120:34-45. doi: 10.1016/j.lungcan.2018.03.022. Epub 2018 Mar 26.
2018
AO Ordine Mauriziano

Kopecka J; Salaroglio IC; Righi L; Libener R; Orecchia S; Grosso F; Milosevic V; Ananthanarayanan P; Ricci L; Capelletto E; Pradotto M; Napoli F; Di Maio M; Novello S; Rubinstein M; Scagliotti GV; Riganti C;

Implications of KRAS mutations in acquired resistance to treatment in NSCLC. in Oncotarget / Oncotarget. 2017 Dec 21;9(5):6630-6643. doi: 10.18632/oncotarget.23553. eCollection 2018 Jan 19.
2018
AO Ordine Mauriziano

Del Re M; Rofi E; Restante G; Crucitta S; Arrigoni E; Fogli S; Di Maio M; Petrini I; Danesi R;

Antiandrogen withdrawal syndrome (AAWS) in the treatment of patients with prostate cancer. in Endocrine-related cancer / Endocr Relat Cancer. 2018 Jan;25(1):R1-R9. doi: 10.1530/ERC-17-0355. Epub 2017 Sep 28.
2018
AO Ordine Mauriziano

Leone G; Tucci M; Buttigliero C; Zichi C; Pignataro D; Bironzo P; Vignani F; Scagliotti GV; Di Maio M;

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study. in Clinical lung cancer / Clin Lung Cancer. 2018 Jan;19(1):93-104. doi: 10.1016/j.cllc.2017.05.016. Epub 2017 Jun 1.
2018
AO Ordine Mauriziano

Pilotto S; Rossi A; Vavalà T; Follador A; Tiseo M; Galetta D; Morabito A; Di Maio M; Martelli O; Caffo O; Piovano PL; Cortinovis D; Zilembo N; Casartelli C; Banna GL; Ardizzoia A; Barzelloni ML; Bearz A; Genestreti G; Mucciarini C; Filipazzi V; Menis J; Rizzo E; Barbieri F; Rijavec E; Cecere F; Spitaleri G; Bria E; Novello S; et alii...

Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression. in Oncotarget / Oncotarget. 2018 Jan 3;9(11):9661-9671. doi: 10.18632/oncotarget.23800. eCollection 2018 Feb 9.
2018
AO Ordine Mauriziano

Trombetta D; Graziano P; Scarpa A; Sparaneo A; Rossi G; Rossi A; Di Maio M; Antonello D; Mafficini A; Fabrizio FP; Manzorra MC; Balsamo T; Centra F; Simbolo M; Pantalone A; Notarangelo M; Parente P; Lucia Dimitri MC; Bonfitto A; Fiordelisi F; Storlazzi CT; L'Abbate A; Taurchini M; Maiello E; Fazio VM; Muscarella LA;

A systematic review of the safety profile of the different combinations of fluoropyrimidines and oxaliplatin in the treatment of colorectal cancer patients. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Feb;122:21-29. doi: 10.1016/j.critrevonc.2017.12.010. Epub 2017 Dec 16.
2018
AO Ordine Mauriziano

Baratelli C; Zichi C; Di Maio M; Brizzi MP; Sonetto C; Scagliotti GV; Tampellini M;

Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Dec 1;29(12):2288-2295. doi: 10.1093/annonc/mdy449.
2018
AO Ordine Mauriziano

Marandino L; La Salvia A; Sonetto C; De Luca E; Pignataro D; Zichi C; Di Stefano RF; Ghisoni E; Lombardi P; Mariniello A; Reale ML; Trevisi E; Leone G; Muratori L; Marcato M; Bironzo P; Novello S; Aglietta M; Scagliotti GV; Perrone F; Di Maio M;

Metastatic Renal Medullary Carcinoma Treated With Immune Checkpoint Inhibitor: Case Report and Literature Review. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2018 Dec;16(6):e1087-e1090. doi: 10.1016/j.clgc.2018.07.011. Epub 2018 Jul 2
2018
AO Ordine Mauriziano

Di Stefano RF; Buttigliero C; De Luca E; Reale ML; Pisano C; Leone G; Zichi C; Massa F; Manfredi M; Vignani F; Bollito E; Porpiglia F; Di Maio M; Tucci M;

The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients. in Breast (Edinburgh, Scotland) / Breast. 2018 Dec;42:41-49. doi: 10.1016/j.breast.2018.08.099. Epub 2018 Aug 22.
2018
AO Ordine Mauriziano

Lambertini M; Di Maio M; Pagani O; Curigliano G; Poggio F; Del Mastro L; Paluch-Shimon S; Loibl S; Partridge AH; Demeestere I; Azim HA Jr; Peccatori FA;

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues. in Gastroenterology / Gastroenterology. 2018 Aug;155(2):479-489.e7. doi: 10.1053/j.gastro.2018.04.010. Epub 2018 Apr 13.
2018
AO Cuneo
AO Ordine Mauriziano

Prinzi N; Concas L; Femia D; Garattini SK; Tafuto S; Bajetta E; Di Costanzo F; Torniai M; Zaniboni A; Ortolani S; Panzuto F; Puliafito I; Colao A; Brighi N; La Salvia A; Bongiovanni A; Cavalcoli F; Fazio N; Duro M; Ricci S; Cauchi C; Davì MV; Carnaghi C; Razzore P; Fontana A; Ermacora P; Perfetti V; De Divitiis C; Catena L; et alii...

Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide. in Clinical and translational radiation oncology / Clin Transl Radiat Oncol. 2018 Aug 13;12:47-52. doi: 10.1016/j.ctro.2018.08.001. eCollection 2018 Au
2018
AO Ordine Mauriziano

Merlano MC; Merlotti AM; Licitra L; Denaro N; Fea E; Galizia D; Di Maio M; Fruttero C; Curcio P; Vecchio S; Russi EG; Corvò R;

Chemotherapy-Induced Neutropenia and Outcome in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With First-Line Docetaxel. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2018 Aug;16(4):318-324. doi: 10.1016/j.clgc.2018.05.006. Epub 2018 Jun 1.
2018
AOU Alessandria
AO Ordine Mauriziano

Scagliotti GV; Guglielmini P; Numico G; Lacidogna G; Pignataro D; Zichi C; Leone G; Di Stefano RF; Vignani F; Tucci M; Buttigliero C; Di Maio M;

Exposure to Multiple Lines of Treatment and Survival of Patients With Metastatic Renal Cell Carcinoma: A Real-world Analysis. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2018 Aug;16(4):e735-e742. doi: 10.1016/j.clgc.2018.01.016. Epub 2018 Feb 5.
2018
AO Ordine Mauriziano

Ratta R; Verzoni E; Di Maio M; Grassi P; Colecchia M; Fucà G; de Braud F; Procopio G;

Hormonal treatment and quality of life of prostate cancer patients: new evidence. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2018 Apr;70(2):144-151. doi: 10.23736/S0393-2249.17.03066-1. Epub 2017 Dec 14.
2018
AO Ordine Mauriziano

Tucci M; Leone G; Buttigliero C; Zichi C; DI Stefano RF; Pignataro D; Vignani F; Scagliotti GV; DI Maio M;

Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Apr;124:21-28. doi: 10.1016/j.critrevonc.2018.02.001. Epub 2018 Feb 7.
2018
AO Ordine Mauriziano

Di Maio M; Baratelli C; Bironzo P; Vignani F; Bria E; Sperti E; Marcato M; Roila F;

Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions. in OncoTargets and therapy / Onco Targets Ther. 2018 Oct 24;11:7353-7368. doi: 10.2147/OTT.S153764. eCollection 2018.
2018
AO Ordine Mauriziano

Tucci M; Zichi C; Buttigliero C; Vignani F; Scagliotti GV; Di Maio M;

2018
AO Ordine Mauriziano

Dieci MV; Massari F; Giusti R; Inno A; Lombardi G; Noto L; Passaro A; Pietrantonio F; Spada F; Valente M; Di Maio M; Torri V;

Is There Room for Second-Line Treatment of Pleural Malignant Mesothelioma? in JAMA oncology / JAMA Oncol. 2017 Sep 1;3(9):1170-1171. doi: 10.1001/jamaoncol.2016.6135.
2017
AO Ordine Mauriziano

Addeo A; Buffoni L; Di Maio M;

Outcomes research: Integrating PROs into the clinic - overall survival benefit or not, it's worth the trouble. in Nature reviews. Clinical oncology / Nat Rev Clin Oncol. 2017 Sep;14(9):529-530. doi: 10.1038/nrclinonc.2017.109. Epub 2017 Jul 18.
2017
AO Ordine Mauriziano

Sperti E; Di Maio M;

Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2017 Sep;111:30-37. doi: 10.1016/j.lungcan.2017.06.009. Epub 2017 Jun 16.
2017
AO Ordine Mauriziano

Gobbini E; Galetta D; Tiseo M; Graziano P; Rossi A; Bria E; Di Maio M; Rossi G; Gregorc V; Riccardi F; Scotti V; Ceribelli A; Buffoni L; Delmonte A; Franchina T; Migliorino MR; Cortinovis D; Pisconti S; Bordi P; Catino A; Maiello E; Arizio F; Novello S;

Selection of Non-small Cell Lung Cancer Patients for Intercalated Chemotherapy and Tyrosine Kinase Inhibitors. in Radiology and oncology / Radiol Oncol. 2017 Jul 18;51(3):241-251. doi: 10.1515/raon-2017-0029. eCollection 2017 Sep.
2017
AO Ordine Mauriziano

Zwitter M; Rossi A; Di Maio M; Perme MP; Lopes G;

Chemotherapy and intercalated gefitinib or erlotinib in the treatment of advanced non-small-cell lung cancer. in Expert review of respiratory medicine / Expert Rev Respir Med. 2017 Mar;11(3):171-180. doi: 10.1080/17476348.2017.1290526. Epub 2017 Feb 9.
2017
AO Ordine Mauriziano

Rossi A; La Salvia A; Di Maio M;

Patients' perception of chemotherapy side effects: Expectations, doctor-patient communication and impact on quality of life - An Italian survey. in European journal of cancer care / Eur J Cancer Care (Engl). 2017 Mar;26(2). doi: 10.1111/ecc.12618. Epub 2016 Dec 22.
2017
AO Ordine Mauriziano

Lorusso D; Bria E; Costantini A; Di Maio M; Rosti G; Mancuso A; Lorusso D; Bria E; Costantini A; Di Maio M; Rosti G; Mancuso A;

A Case Where Switching the End Points for Clinical Trial Interpretation Might Be the Right Choice. in JAMA oncology / JAMA Oncol. 2017 Jun 1;3(6):735-736. doi: 10.1001/jamaoncol.2016.4896.
2017
AO Ordine Mauriziano

Perrone F; Di Maio M; Del Mastro L;

2017
AO Ordine Mauriziano

Morabito A; Daniele G; Costanzo R; Favaretto AG; Filipazzi V; Rossi A; Gebbia V; Castiglione F; Cavanna L; Maiello E; Sandomenico C; Bonanno L; Piazza E; Maione P; Piccirillo MC; Di Maio M; Rocco G; Gallo C; Perrone F; Gridelli C;

Surrogate Endpoints in Second-Line Trials of Targeted Agents in Metastatic Colorectal Cancer: A Literature-Based Systematic Review and Meta-Analysis. in Cancer research and treatment / Cancer Res Treat. 2017 Jul;49(3):834-845. doi: 10.4143/crt.2016.249. Epub 2016 Nov 15.
2017
AO Ordine Mauriziano

Loupakis F; Braud F; Bartolomeo MD; Sonetto C; Bironzo P; Nichetti F; Borelli B; Marmorino F; Salvatore L; Baratelli C; Tampellini M; Berenato R; Pietrantonio F; Antoniotti C; Cremolini C; Falcone A; Di Maio M;

Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Dec 1;28(12):3009-3014. doi: 10.1093/annonc/mdx546.
2017
AO Ordine Mauriziano

Cremolini C; Morano F; Moretto R; Berenato R; Tamborini E; Perrone F; Rossini D; Gloghini A; Busico A; Zucchelli G; Baratelli C; Tamburini E; Tampellini M; Sensi E; Fucà G; Volpi C; Milione M; Di Maio M; Fontanini G; De Braud F; Falcone A; Pietrantonio F;

Quality of life: an important element of treatment value. in The Lancet. Oncology / Lancet Oncol. 2017 Dec;18(12):1557-1558. doi: 10.1016/S1470-2045(17)30697-6. Epub 2017 Nov 9.
2017
AO Ordine Mauriziano

Di Maio M;

Can intercalating chemotherapy with epidermal growth factor receptor inhibitors delay development of treatment resistance in advanced non-small cell lung cancer? in Expert opinion on pharmacotherapy / Expert Opin Pharmacother. 2017 Dec;18(18):1899-1902. doi: 10.1080/14656566.2017.1409721. Epub 2017 N
2017
AO Ordine Mauriziano

La Salvia A; De Luca E; Rossi A; Di Maio M;

[Let's go forward, but wisely…]. in Recenti progressi in medicina / Recenti Prog Med. 2017 Dec;108(12):494-496. doi: 10.1701/2829.28578.
2017
AO Ordine Mauriziano

Di Maio M;

An exploratory analysis of the association between levels of hormones implied in steroid biosynthesis and activity of abiraterone in patients with metastatic castration-resistant prostate cancer. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2017 Aug;69(4):349-358. doi: 10.23736/S0393-2249.16.02746-6. Epub 2016 Dec 22.
2017
AO Ordine Mauriziano

DI Maio M; Scagliotti GV; Berruti A; Buttigliero C; Aroasio E; Vignani F; Bertaglia V; Tucci M;

Zoledronic Acid Dosing Interval for Metastatic Cancer. in JAMA / JAMA. 2017 Apr 11;317(14):1477-1478. doi: 10.1001/jama.2017.2562.
2017
AO Ordine Mauriziano

Tucci M; Buttigliero C; Di Maio M;

Immediate or Delayed Nephrectomy in Patients With Metastatic Renal Cancer Who Are Receiving Targeted Agents: Is the Analysis at Risk for Guarantee-Time Bias? in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2017 Apr 10;35(11):1264. doi: 10.1200/JCO.2016.69.3580. Epub 2017 Feb 6.
2017
AO Ordine Mauriziano

Buttigliero C; Tucci M; Vignani F; Di Maio M;

Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives. in BioMed research international / Biomed Res Int. 2017;2017:5618174. doi: 10.1155/2017/5618174. Epub 2017 Jun 7.
2017
AO Ordine Mauriziano

Zichi C; Tucci M; Leone G; Buttigliero C; Vignani F; Pignataro D; Scagliotti GV; Di Maio M;

Systemic treatment of hepatocellular carcinoma: why so many failures in the development of new drugs? in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2016 Oct;16(10):1053-62. doi: 10.1080/14737140.2016.1227706. Epub 2016 S
2016
AO Ordine Mauriziano

Brizzi MP; Pignataro D; Tampellini M; Scagliotti GV; Di Maio M;

Measuring the Real Clinical Impact of Randomized Clinical Trials in Oncology: Beyond Citation Counts. in JAMA oncology / JAMA Oncol. 2016 Nov 1;2(11):1510-1511. doi: 10.1001/jamaoncol.2016.1779.
2016
AO Ordine Mauriziano

Di Maio M; Baratelli C; Tampellini M;

Lessons from clinical trials on quality-of-life assessment in ovarian cancer trials. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2016 Jun;27(6):961-962. doi: 10.1093/annonc/mdw153. Epub 2016 Apr 7.
2016
AO Ordine Mauriziano

Di Maio M; Perrone F;

Tackling ALK in non-small cell lung cancer: the role of novel inhibitors. in Translational lung cancer research / Transl Lung Cancer Res. 2016 Jun;5(3):301-21. doi: 10.21037/tlcr.2016.06.10.
2016
AO Ordine Mauriziano

Facchinetti F; Tiseo M; Di Maio M; Graziano P; Bria E; Rossi G; Novello S;

LUX-Lung 7: is there enough data for a final conclusion? in The Lancet. Oncology / Lancet Oncol. 2016 Jul;17(7):e266. doi: 10.1016/S1470-2045(16)30116-4.
2016
AO Ordine Mauriziano

Di Maio M; Addeo A;

Ethics in oncology: principles and responsibilities declared in the Italian Ragusa statement. in Tumori / Tumori. 2016 Dec 1;102(6):e25-e27. doi: 10.5301/tj.5000582.
2016
AO Ordine Mauriziano

Gori S; Pinto C; Caminiti C; Aprile G; Marchetti P; Perrone F; Di Maio M; Omodeo Salè E; Mancuso A; De Cicco M; Di Costanzo F; Crispino S; Passalacqua R; Merlano M; Zagonel V; Fioretto L; Micallo G; Labianca R; Bordonaro R; Comandone A; Spinsanti S; Iacono C; Nicolis F;

2016
AO Ordine Mauriziano

Di Maio M; Bruzzi P; Perrone F; Torri V; Montemurro F; Tiseo M; Vasile E;

The ICET-A Survey on Current Criteria Used by Clinicians for the Assessment of Central Adrenal Insufficiency in Thalassemia: Analysis of Results and Recommendations. in Mediterranean journal of hematology and infectious diseases / Mediterr J Hematol Infect Dis. 2016 Jul 1;8(1):e2016034. doi: 10.4084/MJHID.2016.034. eCollection 20
2016
AO Ordine Mauriziano

De Sanctis V; Soliman AT; Elsedfy H; Albu A; Al Jaouni S; Yaarubi SA; Anastasi S; Canatan D; Di Maio M; Di Maio S; El Kholy M; Karimi M; Khater D; Kilinc Y; Lum SH; Skordis N; Sobti P; Stoeva I; Tzoulis P; Wali Y; Kattamis C;